Considerations on equity in management of end stage kidney disease in low- and middle-income countries
Achievement of equity in health requires development of a health system in which everyone has a fair opportunity to attain their full health potential. The current, large country-level variation in the reported incidence and prevalence of treated end-stage kidney disease indicates the existence of s...
| Main Authors: | , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Elsevier
2020
|
| _version_ | 1797058069283209216 |
|---|---|
| author | Van Biesen, W Jha, V Abu-Alfa, A Et al. |
| author_facet | Van Biesen, W Jha, V Abu-Alfa, A Et al. |
| author_sort | Van Biesen, W |
| collection | OXFORD |
| description | Achievement of equity in health requires development of a health system in which everyone has a fair opportunity to attain their full health potential. The current, large country-level variation in the reported incidence and prevalence of treated end-stage kidney disease indicates the existence of system-level inequities. Equitable implementation of kidney replacement therapy (KRT) programs must address issues of availability, affordability, and acceptability. The major structural factors that impact equity in KRT in different countries are the organization of health systems, overall health care spending, funding and delivery models, and nature of KRT prioritization (transplantation, hemodialysis or peritoneal dialysis, and conservative care). Implementation of KRT programs has the potential to exacerbate inequity unless equity is deliberately addressed. In this review, we summarize discussions on equitable provision of KRT in low- and middle-income countries and suggest areas for future research.
|
| first_indexed | 2024-03-06T19:45:23Z |
| format | Journal article |
| id | oxford-uuid:22210c3e-6b81-44f2-ad42-e15ebc5427e5 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T19:45:23Z |
| publishDate | 2020 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oxford-uuid:22210c3e-6b81-44f2-ad42-e15ebc5427e52022-03-26T11:37:00ZConsiderations on equity in management of end stage kidney disease in low- and middle-income countriesJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:22210c3e-6b81-44f2-ad42-e15ebc5427e5EnglishSymplectic Elements at OxfordElsevier2020Van Biesen, WJha, VAbu-Alfa, AEt al.Achievement of equity in health requires development of a health system in which everyone has a fair opportunity to attain their full health potential. The current, large country-level variation in the reported incidence and prevalence of treated end-stage kidney disease indicates the existence of system-level inequities. Equitable implementation of kidney replacement therapy (KRT) programs must address issues of availability, affordability, and acceptability. The major structural factors that impact equity in KRT in different countries are the organization of health systems, overall health care spending, funding and delivery models, and nature of KRT prioritization (transplantation, hemodialysis or peritoneal dialysis, and conservative care). Implementation of KRT programs has the potential to exacerbate inequity unless equity is deliberately addressed. In this review, we summarize discussions on equitable provision of KRT in low- and middle-income countries and suggest areas for future research. |
| spellingShingle | Van Biesen, W Jha, V Abu-Alfa, A Et al. Considerations on equity in management of end stage kidney disease in low- and middle-income countries |
| title | Considerations on equity in management of end stage kidney disease in low- and middle-income countries |
| title_full | Considerations on equity in management of end stage kidney disease in low- and middle-income countries |
| title_fullStr | Considerations on equity in management of end stage kidney disease in low- and middle-income countries |
| title_full_unstemmed | Considerations on equity in management of end stage kidney disease in low- and middle-income countries |
| title_short | Considerations on equity in management of end stage kidney disease in low- and middle-income countries |
| title_sort | considerations on equity in management of end stage kidney disease in low and middle income countries |
| work_keys_str_mv | AT vanbiesenw considerationsonequityinmanagementofendstagekidneydiseaseinlowandmiddleincomecountries AT jhav considerationsonequityinmanagementofendstagekidneydiseaseinlowandmiddleincomecountries AT abualfaa considerationsonequityinmanagementofendstagekidneydiseaseinlowandmiddleincomecountries AT etal considerationsonequityinmanagementofendstagekidneydiseaseinlowandmiddleincomecountries |